In particular, selective glucocorticoid receptor (GR) agonists/modulators (SEGRAMs) of natural and synthetic origin are considered anti-cancer and anti-inflammatory drugs with an improved therapeutic index [22,47,48,49,50,51,52,53,54,55,56,57,58,59,60]. Here, NR3C1 is linked to cancer.